The TEST TARGET TREAT brand, founded in 2012 (Switzerland), from 362 sister brands and 2279 competing brands. The TEST TARGET TREAT brand is owned by Abbott Laboratories, a company listed in New York. TEST TARGET TREAT belongs to the Medical Devices & Instruments business sector.
Share price and profitability of the share Abbott Laboratories (TEST TARGET TREAT)
Buy Abbott Laboratories share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Abbott Laboratories
(TEST TARGET TREAT)
over 5 years*
USD 146.66
Stock market history Abbott Laboratories (TEST TARGET TREAT)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
